PDZ scaffold regulation of astrocytic glutamate receptors and transporters
PDZ scaffold regulation of astrocytic glutamate receptors and transporters
批准号:
8212243
负责人:
Randy A. Hall
金额:
$29.91万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-01 至 2013-01-31
关键词:
AddressAlzheimer&aposs DiseaseAmyotrophic Lateral SclerosisAntibodiesAstrocytesBindingBrainBrain DiseasesClinicalConsensusCustomDataElectron MicroscopyExhibitsGlutamate ReceptorGlutamate TransporterGlutamatesHealthKnockout MiceLanguageMetabotropic Glutamate ReceptorsMusNeuraxisNeuronsNeurotransmittersParkinson DiseasePlayPopulationProtein Binding DomainProteinsProteomicsPublished CommentRegulationScaffolding ProteinSchizophreniaSignal TransductionSliceSorting - Cell MovementStrokeSynapsesSynaptic CleftTestingTextWorkbrain tissueimprovedin vivometabotropic glutamate receptor 3receptorresearch studyscaffoldsodium-hydrogen exchanger regulatory factortherapeutic target
中文摘要
描述(由申请人提供):谷氨酸是哺乳动物中枢神经系统中的主要兴奋性神经递质。神经元之间的谷氨酸能信号传导受到邻近星形胶质细胞的严格调节,星形胶质细胞围绕大多数突触连接并表达特定的谷氨酸转运蛋白,其通过从突触间隙中去除谷氨酸来控制谷氨酸浓度。星形胶质细胞还表达谷氨酸受体,特别是代谢型谷氨酸受体亚型mGluR 3和mGluR 5,其被谷氨酸激活并已知调节谷氨酸转运蛋白活性。虽然我们对神经元中谷氨酸受体的调节和分类了解很多,但对星形胶质细胞中谷氨酸受体和转运蛋白的专门调节潜力却知之甚少。mGluR亚型3和5,以及星形胶质细胞谷氨酸转运蛋白EAAT 1,都具有大的细胞内羧基末端(CT),在控制其活性中发挥关键作用。由于这些CT终止于与一类保守的蛋白质-蛋白质相互作用结构域(称为PDZ结构域)潜在相关的共有基序中,我们筛选了定制的PDZ结构域蛋白质组阵列,发现mGluR 3、mGluR 5和EAAT 1的CT都表现出与多功能支架蛋白NHERF-2的PDZ结构域的稳健和特异性相互作用。这些相互作用在细胞环境中得到了证实,免疫组织化学研究表明,NHERF-2在大脑中的星形胶质细胞中大量表达。我们假设NHERF-2是星形胶质细胞中mGluRs和EAAT 1活性和定位的中心调节因子,并且可能促进mGluRs和谷氨酸转运体之间的相互调节。我们将通过检查NHERF-2对mGluR 3、mGluR 5和EAAT 1功能活性的调节和串扰,以及通过对野生型与NHERF-2敲除小鼠的脑组织进行免疫组织化学分析来探索NHERF-2可能控制mGluR和EAAT 1体内定位的可能性,来测试这一想法。这些研究具有重要的临床意义,因为代谢型谷氨酸受体和谷氨酸转运体被认为是治疗中风、阿尔茨海默病、帕金森病、肌萎缩侧索硬化症、精神分裂症和其他脑疾病的极好的潜在治疗靶点。星形胶质细胞和神经元在整个大脑中相互混合,星形胶质细胞具有可以感知神经元活动的受体以及可以调节突触神经递质水平的转运蛋白。星形胶质细胞受体和转运蛋白通常聚集在突触附近,并被高度调节,但这种靶向和调节的机制在很大程度上是未知的。本申请中描述的工作将探索星形胶质细胞受体和转运蛋白,特别是那些对神经递质谷氨酸有反应的受体和转运蛋白的靶向和调节机制。这些研究具有重要的临床意义,因为星形胶质细胞谷氨酸受体和转运蛋白被认为是治疗中风、阿尔茨海默病、帕金森病、肌萎缩侧索硬化症、精神分裂症和其他脑疾病的极好的潜在治疗靶点。
英文摘要
DESCRIPTION (provided by applicant): Glutamate is the primary excitatory neurotransmitter in the mammalian central nervous system. Glutamatergic signaling between neurons is critically regulated by neighboring astrocytes, which surround most synaptic junctions and express specific glutamate transporters that control glutamate concentrations by removing glutamate from the synaptic cleft. Astrocytes also express glutamate receptors, specifically the metabotropic glutamate receptor subtypes mGluR3 and mGluR5, which are activated by glutamate and known to regulate glutamate transporter activity. Whereas much is known about the regulation and sorting of glutamate receptors in neurons, very little is known about the potential for specialized regulation of glutamate receptors and transporters in astrocytes. The mGluR subtypes 3 and 5, as well as the astrocytic glutamate transporter EAAT1, all possess large intracellular carboxyl-termini (CT) that play key roles in the control of their activity. Since these CTs terminate in consensus motifs for potential association with a class of conserved protein-protein interaction domains known as PDZ domains, we screened a custom-made PDZ domain proteomic array and found that the CTs of mGluR3, mGluR5 and EAAT1 all exhibit robust and specific interactions with the PDZ domains of the multifunctional scaffold protein NHERF-2. These interactions were confirmed in a cellular context, and immunohistochemical studies revealed that NHERF-2 is abundantly expressed in astrocytes in the brain. We hypothesize that NHERF-2 is a central regulator of the activity and localization of mGluRs and EAAT1 in astrocytes, and may facilitate mutual regulation between mGluRs and glutamate transporters. We will test this idea by examining NHERF-2 regulation of mGluR3, mGluR5 and EAAT1 functional activity and cross-talk, as well as by exploring the possibility that NHERF-2 may control mGluR and EAAT1 localization in vivo by performing immunohistochemical analyses on brain tissue from wild-type versus NHERF-2 knockout mice. These studies are of significant clinical importance because metabotropic glutamate receptors and glutamate transporters are considered to be excellent potential therapeutic targets in the treatment of stroke, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, schizophrenia, and other brain disorders. PUBLIC HEALTH RELEVANCE Astrocytes and neurons are intermingled throughout the brain, and astrocytes possess receptors that can sense neuronal activity as well as transporters that can regulate the levels of synaptic neurotransmitters. Astrocytic receptors and transporters are often clustered near synapses and known to be highly regulated, but the mechanisms underlying this targeting and regulation are largely unknown. The work described in this application will explore the mechanisms by which astrocytic receptors and transporters, specifically those that respond to the neurotransmitter glutamate, are targeted and regulated. These studies are of significant clinical importance because astrocytic glutamate receptors and transporters are considered to be excellent potential therapeutic targets in the treatment of stroke, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, schizophrenia, and other brain disorders.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Detection and characterization of receptor interactions with PDZ domains.
受体与 PDZ 结构域相互作用的检测和表征。
DOI:
10.1007/978-1-61779-160-4_21
发表时间:
2011
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Ritter,StefanieL, Hall,RandyA]
通讯作者:
Hall,RandyA
DOI:
10.1038/nrm2803
发表时间:
2009-12
期刊:
Nature reviews. Molecular cell biology
影响因子:
--
作者:
[]
通讯作者:
Disease-Associated Mutations and Ligand Activation of the Adhesion G Protein-Coupled Receptor ADGRB2
-
批准号:10811019
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2023
-
负责人:Randy A. Hall
-
依托单位:
Graduate Training in the Pharmacological Sciences
-
批准号:10628838
-
项目类别:
-
资助金额:$42.44万
-
财政年份:2023
-
负责人:Randy A. Hall
-
依托单位:
Control of Seizure and Migraine Susceptibility by GPR37L1
-
批准号:10449353
-
项目类别:
-
资助金额:$48.78万
-
财政年份:2021
-
负责人:Randy A. Hall
-
依托单位:
Control of Seizure and Migraine Susceptibility by GPR37L1
-
批准号:10279634
-
项目类别:
-
资助金额:$50.17万
-
财政年份:2021
-
负责人:Randy A. Hall
-
依托单位:
Control of Seizure and Migraine Susceptibility by GPR37L1
-
批准号:10651823
-
项目类别:
-
资助金额:$48.78万
-
财政年份:2021
-
负责人:Randy A. Hall
-
依托单位:
Activation and Regulation of the Synaptic Receptor BAI1
-
批准号:9900070
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2019
-
负责人:Randy A. Hall
-
依托单位:
BAI2 mutation associated with a novel neurological disorder
-
批准号:8877775
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2015
-
负责人:Randy A. Hall
-
依托单位:
GPR37L1 mutation associated with a novel neurological disorder
-
批准号:8871619
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2015
-
负责人:Randy A. Hall
-
依托单位:
GPR37 & GPR37L1 signaling pathways promoting cell survival: relevance to stroke
-
批准号:8753503
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2014
-
负责人:Randy A. Hall
-
依托单位:
GPR37 & GPR37L1 signaling pathways promoting cell survival: relevance to stroke
-
批准号:9464568
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2014
-
负责人:Randy A. Hall
-
依托单位:
GPR37 & GPR37L1 signaling pathways promoting cell survival: relevance to stroke
-
批准号:9117648
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2014
-
负责人:Randy A. Hall
-
依托单位:
Activation of GPR37 and GPR37L1 by prosaptide, a neuroprotective peptide
-
批准号:8430491
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2012
-
负责人:Randy A. Hall
-
依托单位:
Activation of GPR37 and GPR37L1 by prosaptide, a neuroprotective peptide
-
批准号:8550157
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2012
-
负责人:Randy A. Hall
-
依托单位:
Activation and regulation of the neural stem cell-expressed receptor GPR56
-
批准号:8431368
-
项目类别:
-
资助金额:$32.72万
-
财政年份:2011
-
负责人:Randy A. Hall
-
依托单位:
Activation and regulation of the neural stem cell-expressed receptor GPR56
-
批准号:8619669
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2011
-
负责人:Randy A. Hall
-
依托单位:
Activation and regulation of the neural stem cell-expressed receptor GPR56
-
批准号:8186265
-
项目类别:
-
资助金额:$33.91万
-
财政年份:2011
-
负责人:Randy A. Hall
-
依托单位:
Activation and regulation of the neural stem cell-expressed receptor GPR56
-
批准号:8269907
-
项目类别:
-
资助金额:$33.91万
-
财政年份:2011
-
负责人:Randy A. Hall
-
依托单位:
Fundamental Mechanisms of GPR56 Activation and Regulation
-
批准号:7758296
-
项目类别:
-
资助金额:$13.43万
-
财政年份:2009
-
负责人:Randy A. Hall
-
依托单位:
PDZ scaffold regulation of astrocytic glutamate receptors and transporters
-
批准号:8018562
-
项目类别:
-
资助金额:$29.91万
-
财政年份:2008
-
负责人:Randy A. Hall
-
依托单位:
PDZ scaffold regulation of astrocytic glutamate receptors and transporters
-
批准号:7560000
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2008
-
负责人:Randy A. Hall
-
依托单位: